Coinbase Global (COIN) Rebounded Strongly in Q4
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Hedge Fund - Patient Capital Management
News, Interviews, and Investor Letters
- 1 - 10
- Next >>
Should You Invest in Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Peloton Interactive (PTON) Climbed 85.8% in Q4
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Several Setbacks Dragged CVS Health Corp. (CVS) in Q4
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why IAC (IAC) Slid in Q4
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Crocs (CROX) Slide due to Heydudes’ Struggle to Gain Traction
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Patient Opportunity Equity Strategy Increased its Holdings in Sofi Technologies (SOFI)
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
United Airlines Holdings (UAL) Benefited From Continued Strong Demand
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Patient Opportunity Equity Strategy’s Q4 2024 Investor Letter
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter.
Will QXO (QXO) Become a Long-Term Compounder?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
- 1 - 10
- Next >>